Aptar Pharma extends its CR nasal pump manufacturing capabilities in North America
Aptar Pharma’s Child-Resistant Feature for nasal sprays combines Child-Resistance (CR) and Senior-Friendliness (SF) with its…
Author
COPD market set to hit $14.1 billion by 2025: GlobalData
This steady growth will be driven by factors including an increase in diagnosed prevalent cases and the entry of new…
TLLLF appoints Kiran Mazumdar-Shaw, CMD, Biocon, as trustee
Mazumdar-Shaw intends to help with greater government engagement in order to shape policy around mental health in India
Biocon shareholders approve issue of bonus shares
The bonus shares were approved by way of capitalisation of reserves
Waters collaborates with Wyatt
R&D scientists will receive higher quality information and data 5x faster than ever before
Unichem Laboratories gets EIR for Ghaziabad formulation unit
The receipt indicates the successful closure of the inspection and the queries raised during the audit
Zydus Cadila gets USFDA nod for mesalamine tablets
The company will manufacture the product at its Moraiya facility in Ahmedabad
Natco plans to launch 8-10 branded formulations this year
The company also plans to expand its Hepatitis-C product
Alembic Pharma looks to file 100 ANDAs in US in next three years
The company aims to launch up to 12 products per year in the US during this time